AstraZeneca PLC (AZN)'s U.S. Sales Tumble As Generics Bite
10/28/2010 7:05:16 AM
Bloomberg -- AstraZeneca Plc, the U.K.’s second- biggest drugmaker, fell the most in almost nine months in London trading after saying fourth-quarter comparisons would be “demanding” as generic competition cuts into profit.
comments powered by